A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources

被引:10
|
作者
Giehl, Kathrin A. [1 ]
Kriz, Martin [1 ,2 ]
Grahovac, Maja [1 ]
Ruzicka, Thomas [1 ]
Berking, Carola [1 ]
机构
[1] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany
[2] Klinikum Augsburg, Dept Dermatol & Allergol, D-86156 Augsburg, Germany
关键词
actinic keratosis; ALA; broad-spectrum; photodynamic therapy; controlled trial; red light; NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMA; INTERNATIONAL CONSENSUS; EMITTING-DIODES; DOUBLE-BLIND; BF-200; ALA; PHASE-III; IN-VITRO; PAIN; PLACEBO;
D O I
10.1684/ejd.2014.2364
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) with red light is well established for actinic keratosis (AK). Differences have been observed concerning pain and efficacy rates with different red light sources. Objectives: To compare pain scores, short- and long-term efficacy rates of PDT of multiple AKs when employing different red light sources.. Material and methods: In a controlled trial, 88 patients (310 AK lesions) received ALA-PDT in combination with either visible light (VIS) + water-filtered infrared A (wIRA) light (PhotoDyn (R) 750 (PD750), 580-1400 nm) for 30 min or incoherent light (Waldmann (R) 1200L (Wa1200L), 600-720 nm) for 10-11 min. Followup visits were performed after 1, 3, 6, and 12 months. if there was no complete cure after 1, 3 or 6 months, a second cycle of PDT was performed. Results: Pain scores were significantly lower in patients illuminated with PD750 rather than Wa1200L. Patient complete clearance rates were 85% and 91% after 1 month, 79% and 92% after 3 months, 97% and 92% after 6 months, and 69% and 85% after 12 months in the PD750 and Wa1200L groups, respectively. Lesion complete clearance rates were 94% and 92% after 1 month, 88% and 97% after 3 months, 96% and 95% after 6 months, and 81% and 89% after 12 months in the PD750 and Wa1200L group, respectively. The efficacy rates were not significantly different. Conclusion: A VIS + wIRA light source produced considerably less pain, while efficacy was not much affected in contrast to previously published studies, probably because the illumination time was longer in this study.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [41] Photodynamic Therapy with Daylight: Good Results in Patients with actinic Keratosis
    Drexelius, Nina
    AKTUELLE DERMATOLOGIE, 2018, 44 (10) : 421 - 421
  • [42] Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial
    Pariser, DM
    Lowe, NJ
    Stewart, DM
    Jarratt, MT
    Lucky, AW
    Pariser, RJ
    Yamauchi, PS
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (02) : 227 - 232
  • [43] Photodynamic therapy in the management of actinic keratosis: Retrospective evaluation of outcome
    Jerjes, Waseem
    Hamdoon, Zaid
    Abdulkareem, Ali A.
    Hopper, Colin
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2017, 17 : 200 - 204
  • [44] Photodynamic Therapy for Photodamage, Actinic Keratosis, and Acne in the Cosmetic Practice
    Moy, Lawrence S.
    Frost, Debra
    Moy, Stephanie
    FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA, 2020, 28 (01) : 135 - +
  • [45] Photodynamic therapy with delta-aminolevulinic acid and light-emitting diodes in actinic keratosis
    Ritter, Clarice Gabardo
    Palma Kuhl, Isabel Cristina
    Lenhardt, Carolina
    Weissbluth, Marlene Laks
    Bakos, Renato Marchiori
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2010, 85 (05) : 639 - 645
  • [46] Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomized intra-individual study
    Assikar, S.
    Labrunie, A.
    Kerob, D.
    Couraud, A.
    Bedane, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) : 1730 - 1735
  • [47] Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial
    Rubel, D. M.
    Spelman, L.
    Murrell, D. F.
    See, J. -A.
    Hewitt, D.
    Foley, P.
    Bosc, C.
    Kerob, D.
    Kerrouche, N.
    Wulf, H. C.
    Shumack, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (05) : 1164 - 1171
  • [48] Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis
    Bartosinska, Joanna
    Szczepanik-Kulak, Paulina
    Raczkiewicz, Dorota
    Niewiedziol, Marta
    Gerkowicz, Agnieszka
    Kowalczuk, Dorota
    Kwasny, Miroslaw
    Krasowska, Dorota
    PHARMACEUTICS, 2022, 14 (02)
  • [49] A study of topical methyl-aminolaevulinate red-light photodynamic therapy in the treatment of actinic keratosis in Chinese patients: a Singaporean experience
    Oh, C. C.
    Theng, T. S. C.
    Chong, W. S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2015, 40 (05) : 502 - 506
  • [50] Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: Clinical and histopathologic evaluation
    Kim, HS
    Yoo, JY
    Cho, KH
    Kwon, OS
    Moon, SE
    DERMATOLOGIC SURGERY, 2005, 31 (01) : 33 - 37